Charlottenlund, Denmark

Annette Müllertz

This inventor holds 2 USPTO granted patents. Top assignee: Basf as. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annette Müllertz. Retrieved from https://idiyas.com/inventor/annette-müllertz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Annette Müllertz: Innovator in Drug Delivery Systems

Introduction

Annette Müllertz is a prominent inventor based in Charlottenlund, Denmark. She has made significant contributions to the field of drug delivery systems, particularly through her innovative patent that focuses on lipid compounds and their applications in pharmaceuticals.

Latest Patents

Müllertz holds a patent for a composition that includes a lipid compound, a triglyceride, and a surfactant. This patent details compositions comprising 2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenyloxy)butanoic acid, along with its ester derivatives or pharmaceutically acceptable salts. The patent also discusses methods for using these compositions, which are essential for developing self-emulsifying drug delivery systems such as SEDDS, SMEDDS, or SNEDDS.

Career Highlights

Annette Müllertz is associated with BASF A/S, where she continues to advance her research and development efforts in the pharmaceutical sector. Her work has been instrumental in enhancing the efficacy of drug delivery methods, making her a key figure in her field.

Collaborations

Müllertz has collaborated with notable colleagues, including Svein Olaf Hustvedt and Preben H Olesen. These partnerships have contributed to her innovative research and the successful development of her patented technologies.

Conclusion

Annette Müllertz is a trailblazer in the realm of drug delivery systems, with her patent reflecting her commitment to advancing pharmaceutical science. Her contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…